Arcadia Biosciences (RKDA) Misses Q3 EPS by 2c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.08 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• AeroVironment (AVAV) PT Lowered to $280 at Canaccord
• AeroVironment (AVAV) Tops Q4 EPS by 36c